Recombinant Rhesus Macaque Mamu-A*01 B2M Monomer Protein (HEK293)，Avi & His

Mamu-A*01 B2M monomer is a recombinant protein derived from the rhesus macaque, a primate model that plays a crucial role in immunological studies, particularly in understanding human diseases and vaccine responses. Mamu-A*01 is a major histocompatibility complex (MHC) class I molecule that presents antigens to CD8+ T cells, influencing immune responses during infections and cancer. The study of this protein is vital as it provides insights into T cell recognition and responses, which can differ significantly from those in humans. With the increasing interest in cross-species T cell studies and the development of effective therapeutic strategies, researchers have focused on characterizing Mamu-A*01 B2M monomer to elucidate its structural and functional properties. The development of recombinant forms of this protein allows for better functional assays and improves the understanding of its role in the immune landscape of primates. Moreover, studying this protein can aid in vaccine development processes and enhance our knowledge of viral immunology, given the similarities between non-human primates and humans in immune system responses. Overall, the research surrounding Mamu-A*01 B2M monomer embodies a significant step toward translating findings from non-human primate models into potential clinical applications and improved therapeutic interventions for human diseases.